QALYs Explained: The Metric That’s Shaping—and Dividing—Healthcare Policy

QALYs Explained: The Metric That’s Shaping—and Dividing—Healthcare Policy

2 min read

Quality-Adjusted Life Years (QALYs) are a cornerstone concept in health economics. They measure the value of medical treatments by considering both how long people live and how well they live during that time.

In many countries, QALYs are used to assess the cost-effectiveness of healthcare options. They help guide decisions about insurance coverage, treatment choices, and public health programs, ensuring that resources are allocated where they have the greatest impact.

How QALYs Work

A QALY is calculated by multiplying the number of years someone spends in a particular health state by a utility value between 0 and 1, where 0 represents death and 1 represents perfect health.

For example, living two years with a quality-of-life score of 0.6 equals 1.2 QALYs. This helps illustrate how treatments can extend life, improve quality of life, or achieve both.

Measuring Health Utility

Determining utility values is a central part of QALY measurement. Three common methods are used:

  • Time trade-off: how many years of life someone would give up to avoid a certain health condition.
  • Standard gamble: the level of risk of death a person would accept to avoid living with that condition.
  • Visual analog scale: rating health states on a numerical scale.

These methods rely on people’s preferences and perceptions, since health is deeply personal and difficult to measure objectively.

Global Use and Policy Debate

QALYs are used in more than 80 countries, including the United Kingdom, Canada, and Australia, to inform healthcare funding and coverage decisions. In the United States, however, their use has been limited due to concerns that they may undervalue the lives of people with disabilities or chronic conditions – and this has fueled an ongoing debate about how we measure the value of health and whose perspectives are reflected in those measures.

Exploring Alternatives

As a result, new approaches are being explored. Equal Value of Life Years Gained (EVLYG) values each additional year of life equally, regardless of health quality. Health Years in Total (HYT) combines years lived and quality of life in an additive way rather than multiplying the two.

No single measure has replaced the QALY, but the search for more inclusive and equitable ways to assess health outcomes continues. The future of value-based healthcare may depend on how we choose to define the value of a life well lived.

Other Posts You Might Like

Value-Based Health Care: Shifting the Focus from Quantity to Quality
Value-Based Health Care: Shifting the Focus from Quantity to Quality
Oct 23, 2025
Understand how value-based health care shifts focus from volume to outcomes, rewarding better results, reducing costs and improving patient care....
Read more
Budget Impact Models: A Practical Tool for Healthcare Decision-Making
Budget Impact Models: A Practical Tool for Healthcare Decision-Making
Oct 07, 2025
Learn how Budget Impact Models help payers and HTA agencies assess short-term affordability of new healthcare treatments alongside cost-effectiveness analysis....
Read more
New White Paper: Charting the Landscape of Real-World Data in the U.S.
New White Paper: Charting the Landscape of Real-World Data in the U.S.
Oct 01, 2025
Learn how real-world data is transforming U.S. healthcare and life sciences. Our new white paper maps datasets, applications, challenges, and future directions....
Read more
Chart showing global vaccine trial trends
Polygon Health Analytics Launches Vaccine Trial Atlas: Making Clinical Trial Data Accessible
Sep 16, 2025
The vaccine research and development community has faced unprecedented challenges in recent months, including policy upheavals, leadership changes, research program cancellations, and a surge of misinformation...
Read more
Launchpad
Polygon Health Analytics Celebrates Graduation of 2025 Launchpad Cohort
Sep 03, 2025
[Philadelphia, September 2, 2025] – Polygon Health Analytics proudly announces the successful graduation of its 2025 Launchpad Program cohort—the second since the program’s inception—marking...
Read more
Patient_Reported_With_Doctor
Patient-Reported Outcomes: Bringing the Patient’s Voice into Clinical Development and Outcomes Research
Aug 14, 2025
When it comes to healthcare, numbers and lab results only tell part of the story. What about how patients feel? How treatments impact their daily lives?...
Read more
Powerful AI Starts with High-Quality Data: Lessons from Edwin Chen and Surge AI
Powerful AI Starts with High-Quality Data: Lessons from Edwin Chen and Surge AI
Jul 28, 2025
In a world where AI headlines are dominated by billion-dollar fundraises, massive model sizes, and compute power arms races, Edwin Chen offers a refreshing counter-narrative. As...
Read more
Understanding Health Technology Assessment (HTA): A Strategic Imperative for Innovators
Understanding Health Technology Assessment (HTA): A Strategic Imperative for Innovators
Jul 15, 2025
If you're a scientist transitioning into the biotechnology sector or an entrepreneur developing a novel therapy for an unmet medical need, one term will...
Read more
Literature Reviews
Systematic Literature Reviews and AI: A Gold Standard Meets Innovation
Jun 01, 2025
Discover how Systematic Literature Reviews (SLRs) provide a gold-standard method for evidence synthesis in biomedicine—and how AI is transforming the process. Learn the key steps, differences from other review types, and the future potential of automation in research....
Read more
Perfect timing
No Perfect Timing: Embracing Uncertainty in Business and Life
Apr 16, 2025
"Is now the right time?" It’s a question I hear often—from aspiring entrepreneurs, working parents, and close friends. Whether it’s starting...
Read more
View all